This urinary diagnostic robustly detected PC-3-cell-derived tumours that are prostate-specific antigen (PSA) negative (Supplementary Fig. 4f), suggesting broad utility of synthetic urine biomarkers in tumour types without available clinical blood biomarkers. This evidence concerns the gene KLK3 and neoplasm.